Emerging Biomarkers in Canine Glaucoma: Insights into Clinical, Genetic, Oxidative, and Inflammatory Pathways
DOI:
https://doi.org/10.52331/V31i1dz34Keywords:
canine glaucoma, clinical biomarker, genetic biomarker, inflammation biomarker, oxidative stress biomarkerAbstract
Canine glaucoma is a complex ocular disorder characterized by the progressive loss of retinal ganglion cells (RGCs) and specific optic nerve damage, often resulting in permanent blindness in affected dogs. Recent advancements emphasize the importance of various biomarkers in understanding the development and progression of canine glaucoma, especially concerning clinical signs, genetics, oxidative stress, and inflammation pathways. An imbalance between the production and drainage of aqueous humor significantly impacts intraocular pressure (IOP), a key factor in managing glaucoma. Oxidative stress has emerged as a key contributor to RGC degeneration in canine glaucoma, mirroring findings in human studies, where it is implicated in glaucomatous neurodegeneration. The interaction between oxidative stress and pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) in the aqueous humor reflects a complex biomarker network with potential diagnostic and therapeutic value. The identification of genetic biomarkers, including enzyme and protein variants, also indicates a move toward molecular methods for evaluating glaucoma risk across different dog breeds. Understanding these interconnected factors offers valuable insights into novel treatments and preventative measures, including genetic screening, oxidative stress monitoring, employing anti-inflammatory, and neuroprotective therapies. Continued biomarker research is essential for improving clinical outcomes in canine glaucoma and may also offer translational relevance to human glaucomatous diseases, thereby broadening future therapeutic possibilities.
References
Baudouin, C., Kolko, M., Melik-Parsadaniantz, S., & Messmer, E. M. (2021). Inflammation in Glaucoma: From the back to the front of the eye, and beyond. Progress in Retinal and Eye Research, 83(June). https://doi.org/10.1016/j.preteyeres.2020.100916
Beykin, G., Norcia, A. M., Srinivasan, V. J., Dubra, A., & Goldberg, J. L. (2021). Discovery and clinical translation of novel glaucoma biomarkers. Progress in Retinal and Eye Research, 80(January 2020), 100875. https://doi.org/10.1016/j.preteyeres.2020.100875
Blanca, P. M., María Luisa, F. R., Guadalupe, M., & Fátima, C. L. (2024). Oxidative Stress in Canine Diseases: A Com-prehensive Review. Antioxidants, 13(11), 1–34. https://doi.org/10.3390/antiox13111396
Chen, T., Gionfriddo, J. R., Tai, P. Y., Novakowski, A. N., Alyahya, K., & Madl, J. E. (2015). Oxidative stress increases in retinas of dogs in acute glaucoma but not in chronic glaucoma. Veterinary Ophthalmology, 18(4), 261–270. https://doi.org/10.1111/vop.12177
Dammak, A., Huete-Toral, F., Carpena-Torres, C., Martin, A., Pastrana, C., & Carracedo, G. (2021). From oxidative stress to inflammation in the posterior ocular diseases: Diagnosis and treatment. Pharmaceutics, 13(9), 1–29. https://doi.org/10.3390/pharmaceutics13091376
Dammak, A., Sanchez Naves, J., Huete-Toral, F., & Carracedo, G. (2023). New Biomarker Combination Related to Oxi-dative Stress and Inflammation in Primary Open-Angle Glaucoma. Life, 13(7), 1–16. https://doi.org/10.3390/life13071455
Gough, A. A. (2017). Dog breed screening for glaucoma prevalence. 1–4.
Graham, K. (2019). Biomarkers of canine glaucoma.
Graham, K. L., McCowan, C., & White, A. (2017). Genetic and Biochemical Biomarkers in Canine Glaucoma. Veterinary Pathology, 54(2), 194–203. https://doi.org/10.1177/0300985816666611
Hamor, R. (2013). Clinical Considerations With Glaucoma. 1–4. https://vetmed.illinois.edu/wp-content/uploads/2014/04/Glaucoma-Considerations.pdf
Hondur, G., Göktasş, E., Yang, X., Al-Aswad, L., Auran, J. D., Blumberg, D. M., Cioffi, G. A., Liebmann, J. M., Suh, L. H., Trief, D., & Tezel, G. (2017). Oxidative stress–related molecular biomarker candidates for glaucoma. Investigative Ophthalmology and Visual Science, 58(10), 4078–4088. https://doi.org/10.1167/iovs.17-22242
Izzotti, A., Bagnis, A., & Saccà, S. C. (2006). The role of oxidative stress in glaucoma. Mutation Research - Reviews in Mutation Research, 612(2), 105–114. https://doi.org/10.1016/j.mrrev.2005.11.001
Javier, F., & Martinez, H. (2017). General on Glaucoma and Oxidative Stress. Comments on Study Design: “Biomarkers of Lipid Peroxidation in the Aqueous Humor of Primary Open-angle Glaucoma Patients.” Journal of Eye Diseases and Disorders, 02(01), 2–4. https://doi.org/10.35248/2684-1622.17.2.105
Kato, K., Sasaki, N., Matsunaga, S., Nishimura, R., & Ogawa, H. (2006). Incidence of canine glaucoma with goniodysplasia in Japan : a retrospective study. The Journal of Veterinary Medical Science, 68(8), 853–858. https://doi.org/10.1292/jvms.68.853
Kimura, A., Namekata, K., Guo, X., Noro, T., Harada, C., & Harada, T. (2017). Targeting Oxidative Stress for Treatment of Glaucoma and Optic Neuritis. Oxidative Medicine and Cellular Longevity, 2017. https://doi.org/10.1155/2017/2817252
Komáromy, A. M., Bras, D., Esson, D. W., Fellman, R. L., Grozdanic, S. D., Kagemann, L., Miller, P. E., Moroi, S. E., Plummer, C. E., Sapienza, J. S., Storey, E. S., Teixeira, L. B., Toris, C. B., & Webb, T. R. (2019). The future of canine glaucoma therapy. Veterinary Ophthalmology, 22(5), 726–740. https://doi.org/10.1111/vop.12678
Lin, B., & Li, D. (2025). The pivotal role of inflammatory factors in glaucoma: a systematic review. Frontiers in Immunology, 16(May), 1–9. https://doi.org/10.3389/fimmu.2025.1577200
Park, S. A., & Komáromy, A. M. (2021). Biomechanics of the optic nerve head and sclera in canine glaucoma: A brief review. Veterinary Ophthalmology, 24(4), 316–325. https://doi.org/10.1111/vop.12923
Raut, S. W., Venugopal, S. K., Philip, L. M., Martin, K. D. J., George, A., & Joy, G. (2023). Management of canine glaucoma using a combination of dorzolamide and timolol. Journal of Veterinary and Animal Sciences, 54(4), 1127–1130. https://doi.org/10.51966/jvas.2023.54.4.1127-1130
Saleh, A., Alghamdi, A., Ibrahim, A., Alghamdi, A., Hamed, D., & Alkuwaykibi, M. K. G. (2019). Glaucoma Management Approach : Simple Literature Review. 10(4), 25–28.
Schellack, N. (2016). Glaucoma : a brief review. January 2015.
Sebbag, L., & Pe’er, O. (2024). Role of Inflammation in Canine Primary Glaucoma. Animals, 14(1). https://doi.org/10.3390/ani14010110
Strom, A. R., Hässig, M., Iburg, T. M., & Spiess, B. M. (2011). Epidemiology of canine glaucoma presented to University of Zurich from 1995 to 2009. Part 2: secondary glaucoma (217 cases). Veterinary Ophthalmology. 14 (2): 127–132
Vohra, R., Tsai, J. C., & Kolko, M. (2013). The Role of Inflammation in the Pathogenesis of Glaucoma. Survey of Ophthal-mology, 58(4), 311–320. https://doi.org/10.1016/j.survophthal.2012.08.010
Webb, T. E. R. (2021). A review of glaucoma surgical therapy. Veterinary Ophthalmology, 24(S1), 34–38. https://doi.org/10.1111/vop.12852
Yun, S., Kang, S., Kim, Y., & Seo, K. (2022). A Retrospective Study of Canine Primary Glaucoma (2011-2020). Journal of Veterinary Clinics, 39(4), 162–167. https://doi.org/10.17555/jvc.2022.39.4.162
Zăvoi, A. A., & Enache, A. E. (2021). Glaucoma in Dogs. Cluj Veterinary Journal, 26(3), 8–22. https://doi.org/10.52331/cvj.v26i3.34
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2026 Luh Made Nanda Ayuni, ida Tjahajati, Ida Fitriana
This work is licensed under a Creative Commons Attribution 4.0 International License.
